Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Thrombosis modulates arterial drug distribution for drug-eluting stents.

Hwang CW, Levin AD, Jonas M, Li PH, Edelman ER.

Circulation. 2005 Apr 5;111(13):1619-26. Epub 2005 Mar 28.

2.

Strut position, blood flow, and drug deposition: implications for single and overlapping drug-eluting stents.

Balakrishnan B, Tzafriri AR, Seifert P, Groothuis A, Rogers C, Edelman ER.

Circulation. 2005 Jun 7;111(22):2958-65. Epub 2005 May 31.

3.

The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES).

Serruys PW, Sianos G, Abizaid A, Aoki J, den Heijer P, Bonnier H, Smits P, McClean D, Verheye S, Belardi J, Condado J, Pieper M, Gambone L, Bressers M, Symons J, Sousa E, Litvack F.

J Am Coll Cardiol. 2005 Jul 19;46(2):253-60.

4.

Drug-eluting stents.

García-García HM, Vaina S, Tsuchida K, Serruys PW.

Arch Cardiol Mex. 2006 Jul-Sep;76(3):297-319. Review.

PMID:
17091802
5.

Local and systemic drug competition in drug-eluting stent tissue deposition properties.

Levin AD, Jonas M, Hwang CW, Edelman ER.

J Control Release. 2005 Dec 5;109(1-3):236-43. Epub 2005 Nov 11.

PMID:
16289420
6.
7.

Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis.

Cook S, Ladich E, Nakazawa G, Eshtehardi P, Neidhart M, Vogel R, Togni M, Wenaweser P, Billinger M, Seiler C, Gay S, Meier B, Pichler WJ, Jüni P, Virmani R, Windecker S.

Circulation. 2009 Aug 4;120(5):391-9. doi: 10.1161/CIRCULATIONAHA.109.854398. Epub 2009 Jul 20.

8.

Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials.

Bavry AA, Kumbhani DJ, Helton TJ, Borek PP, Mood GR, Bhatt DL.

Am J Med. 2006 Dec;119(12):1056-61.

PMID:
17145250
9.

Overlapping paclitaxel-eluting stents: long-term effects in a porcine coronary artery model.

Wilson GJ, Polovick JE, Huibregtse BA, Poff BC.

Cardiovasc Res. 2007 Nov 1;76(2):361-72. Epub 2007 Jul 18.

10.

Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model.

Yang W, Ge J, Liu H, Zhao K, Liu X, Qu X, Li W, Huang Y, Sun A, Zou Y.

Cardiovasc Res. 2006 Dec 1;72(3):483-93. Epub 2006 Aug 23.

11.

Toxic vessel reaction to an absorbable polymer-based paclitaxel-eluting stent in pig coronary arteries.

Jabara R, Chronos N, Tondato F, Conway D, Molema W, Park K, Mabin T, King S, Robinson K.

J Invasive Cardiol. 2006 Aug;18(8):383-90.

PMID:
16877788
12.

Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents.

Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, Skorija K, Weber DK, Gold HK, Virmani R.

Circulation. 2005 Jul 12;112(2):270-8. Epub 2005 Jul 5.

13.

Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.

Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, Gold HK, Virmani R.

Circulation. 2007 May 8;115(18):2435-41. Epub 2007 Apr 16.

14.

Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries.

Wilson GJ, Nakazawa G, Schwartz RS, Huibregtse B, Poff B, Herbst TJ, Baim DS, Virmani R.

Circulation. 2009 Jul 14;120(2):141-9, 1-2. doi: 10.1161/CIRCULATIONAHA.107.730010. Epub 2009 Jun 29.

15.

Effects of diffusion coefficients and struts apposition using numerical simulations for drug eluting coronary stents.

Mongrain R, Faik I, Leask RL, Rodés-Cabau J, Larose E, Bertrand OF.

J Biomech Eng. 2007 Oct;129(5):733-42.

PMID:
17887899
16.

Drug clearance and arterial uptake after local perivascular delivery to the rat carotid artery.

Lovich MA, Brown L, Edelman ER.

J Am Coll Cardiol. 1997 Jun;29(7):1645-50.

17.

Local drug delivery: impact of pressure, substance characteristics, and stenting on drug transfer into the arterial wall.

Baumbach A, Herdeg C, Kluge M, Oberhoff M, Lerch M, Haase KK, Wolter C, Schröder S, Karsch KR.

Catheter Cardiovasc Interv. 1999 May;47(1):102-6.

PMID:
10385171
18.

Time dependent vascular and myocardial responses of a second generation, small vessel, paclitaxel-eluting stent platform.

Thompson CA, Huibregtse B, Poff B, Wilson GJ.

Catheter Cardiovasc Interv. 2009 Apr 1;73(5):597-604. doi: 10.1002/ccd.21890.

PMID:
19180652
19.

A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.

Schömig A, Dibra A, Windecker S, Mehilli J, Suárez de Lezo J, Kaiser C, Park SJ, Goy JJ, Lee JH, Di Lorenzo E, Wu J, Jüni P, Pfisterer ME, Meier B, Kastrati A.

J Am Coll Cardiol. 2007 Oct 2;50(14):1373-80. Epub 2007 Aug 21. Review.

20.

A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model.

Bhargava B, Reddy NK, Karthikeyan G, Raju R, Mishra S, Singh S, Waksman R, Virmani R, Somaraju B.

Catheter Cardiovasc Interv. 2006 May;67(5):698-702.

PMID:
16575925
Items per page

Supplemental Content

Write to the Help Desk